Giulio C Spagnoli
GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Nebiker C, Oertli D, von Holzen U, Adamina M, Muraro M, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Bolli M, Rosso R, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser R, Spagnoli G. GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer. Clin Cancer Res 2014; 20:3094-106.
Apr 15, 2014GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Apr 15, 2014Clin Cancer Res 2014; 20:3094-106
Nebiker Christian A, Oertli Daniel, von Holzen Urs, Adamina Michel, Muraro Manuele G, Mengus Chantal, Zajac Paul, Sconocchia Giuseppe, Zuber Markus, Tornillo Luigi, Terracciano Luigi, Bolli Martin, Rosso Raffaele, Han Junyi, Eppenberger-Castori Serenella, Iezzi Giandomenica, Hirt Christian, Amicarella Francesca, Cremonesi Eleonora, Huber Xaver, Padovan Elisabetta, Angrisani Basilio, Droeser Raoul A, Spagnoli Giulio C
Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma
Adamina M, Spagnoli G, Marti W, Oertli D, Heberer M, Jacob A, Huegli R, Bolli M, Viehl C, Frey D, Weber W, Rosenthal R, Zajac P. Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma. Mol Ther 2010; 18:651-9.
Mar 1, 2010Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma
Mar 1, 2010Mol Ther 2010; 18:651-9
Adamina Michel, Spagnoli Giulio C, Marti Walter, Oertli Daniel, Heberer Michael, Jacob Augustinus L, Huegli Rolf W, Bolli Martin, Viehl Carsten T, Frey Daniel M, Weber Walter P, Rosenthal Rachel, Zajac Paul
Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients
Rosenthal R, Heberer M, Oertli D, von Holzen U, Frey D, Weber W, Bolli M, Iezzi G, Zajac P, Feder-Mengus C, Adamina M, Bracci L, Groeper C, Spagnoli G. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients. J Immunother 2009; 32:252-61.
Apr 1, 2009Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients
Apr 1, 2009J Immunother 2009; 32:252-61
Rosenthal Rachel, Heberer Michael, Oertli Daniel, von Holzen Urs, Frey Daniel M, Weber Walter P, Bolli Martin, Iezzi Giandomenica, Zajac Paul, Feder-Mengus Chantal, Adamina Michel, Bracci Laura, Groeper Célia, Spagnoli Giulio C
Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering
Bracci L, Belardelli F, Proietti E, Iezzi G, Zajac P, Groeper C, Rosenthal R, Adamina M, Provenzano M, Schumacher R, Spagnoli G. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering. J Immunother 2008; 31:466-74.
Jun 1, 2008Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering
Jun 1, 2008J Immunother 2008; 31:466-74
Bracci Laura, Belardelli Filippo, Proietti Enrico, Iezzi Giandomenica, Zajac Paul, Groeper Célia, Rosenthal Rachel, Adamina Michel, Provenzano Maurizio, Schumacher Reto, Spagnoli Giulio C
Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
Rosenthal R, Viehl C, Gueller U, Weber W, Adamina M, Spagnoli G, Heberer M, Zuber M. Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal. J Am Coll Surg 2008; 207:95-105.
May 23, 2008Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
May 23, 2008J Am Coll Surg 2008; 207:95-105
Rosenthal Rachel, Viehl Carsten T, Gueller Ulrich, Weber Walter P, Adamina Michel, Spagnoli Giulio C, Heberer Michael, Zuber Markus
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Adamina M, Heberer M, Zuber M, Oertli D, Frey D, Gueller U, Zajac P, Schumacher R, Rosenthal R, Weber W, Spagnoli G. Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial. Contemp Clin Trials 2007; 29:165-81.
Jul 17, 2007Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Jul 17, 2007Contemp Clin Trials 2007; 29:165-81
Adamina Michel, Heberer Michael, Zuber Markus, Oertli Daniel, Frey Daniel M, Gueller Ulrich, Zajac Paul, Schumacher Reto, Rosenthal Rachel, Weber Walter P, Spagnoli Giulio C
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski H, Heberer M, Spagnoli G. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 2007; 120:337-43.
Jan 15, 2007Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
Jan 15, 2007Int J Cancer 2007; 120:337-43
Groeper Célia, Gambazzi Franco, Zajac Paul, Bubendorf Lukas, Adamina Michel, Rosenthal Rachel, Zerkowski Hans-Reinhard, Heberer Michael, Spagnoli Giulio C
Clinical applications of virosomes in cancer immunotherapy
Adamina M, Guller U, Bracci L, Heberer M, Spagnoli G, Schumacher R. Clinical applications of virosomes in cancer immunotherapy. Expert Opin Biol Ther 2006; 6:1113-21.
Nov 1, 2006Clinical applications of virosomes in cancer immunotherapy
Nov 1, 2006Expert Opin Biol Ther 2006; 6:1113-21
Adamina Michel, Guller Ulrich, Bracci Laura, Heberer Michael, Spagnoli Giulio C, Schumacher Reto
Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288)
Cavazza A, Marini M, Spagnoli G, Adamina M, Roda L. Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288). ChemMedChem 2006; 1:816-20.
Aug 1, 2006Permeability of phospholipid vesicles to the tumor antigen epitope gp100(280-288)
Aug 1, 2006ChemMedChem 2006; 1:816-20
Cavazza Antonella, Marini Mario, Spagnoli Giulio C, Adamina Michel, Roda L Giorgio
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Adamina M, Oertli D, Spagnoli G, Amacker M, Zurbriggen R, Feder C, Groeper C, Rosenthal R, Weber W, Zajac P, Schumacher R, Heberer M. Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy. J Liposome Res 2006; 16:195-204.
Jan 1, 2006Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Jan 1, 2006J Liposome Res 2006; 16:195-204
Adamina Michel, Oertli Daniel, Spagnoli Giulio C, Amacker Mario, Zurbriggen Rinaldo, Feder Chantal, Groeper Célia, Rosenthal Rachel, Weber Walter P, Zajac Paul, Schumacher Reto, Heberer Michael
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro
Schumacher R, Amacker M, Neuhaus D, Rosenthal R, Groeper C, Heberer M, Spagnoli G, Zurbriggen R, Adamina M. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro. Vaccine 2005; 23:5572-82.
Aug 15, 2005Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro
Aug 15, 2005Vaccine 2005; 23:5572-82
Schumacher Reto, Amacker Mario, Neuhaus Danielle, Rosenthal Rachel, Groeper Célia, Heberer Michael, Spagnoli Giulio C, Zurbriggen Rinaldo, Adamina Michel
NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study
Bolli M, Spagnoli G, Hudolin T, Terracciano L, Carafa V, Sanguedolce F, Feder C, Gueller U, Zajac P, Schultz-Thater E, Tornillo L. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. Int J Cancer 2005; 115:960-6.
Jul 20, 2005NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study
Jul 20, 2005Int J Cancer 2005; 115:960-6
Bolli Martin, Spagnoli Giulio C, Hudolin Tvrtko, Terracciano Luigi, Carafa Vincenza, Sanguedolce Francesca, Feder Chantal, Gueller Ulrich, Zajac Paul, Schultz-Thater Elke, Tornillo Luigi
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
von Holzen U, Heberer M, Oertli D, Marti W, Schumacher R, Feder C, Reschner A, Groeper C, Zajac P, Weber W, Bolli M, Adamina M, Spagnoli G. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy. Int J Cancer 2005; 115:248-55.
Jun 10, 2005Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
Jun 10, 2005Int J Cancer 2005; 115:248-55
von Holzen Urs, Heberer Michael, Oertli Daniel, Marti Walter, Schumacher Reto, Feder Chantal, Reschner Anca, Groeper Célia, Zajac Paul, Weber Walter P, Bolli Martin, Adamina Michel, Spagnoli Giulio C
Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Spagnoli G, Adamina M, Bolli M, Weber W, Zajac P, Marti W, Oertli D, Heberer M, Harder F. Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation. World J Surg 2005; 29:692-9.
Jun 1, 2005Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Jun 1, 2005World J Surg 2005; 29:692-9
Spagnoli Giulio C, Adamina Michel, Bolli Martin, Weber Walter P, Zajac Paul, Marti Walter, Oertli Daniel, Heberer Michael, Harder Felix
Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells
Cavazza A, Adamina M, Ausiello C, Giardina B, Marini M, Palazzo R, Roda L, Spagnoli G. Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells. Clin Immunol 2004; 111:252-61.
Jun 1, 2004Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells
Jun 1, 2004Clin Immunol 2004; 111:252-61
Cavazza Antonella, Adamina Michel, Ausiello Clara M, Giardina Bruno, Marini Mario, Palazzo Raffaella, Roda L Giorgio, Spagnoli Giulio C
Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation
Schumacher R, Adamina M, Zurbriggen R, Bolli M, Padovan E, Zajac P, Heberer M, Spagnoli G. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation. Vaccine 2004; 22:714-23.
Jan 26, 2004Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation
Jan 26, 2004Vaccine 2004; 22:714-23
Schumacher Reto, Adamina Michel, Zurbriggen Rinaldo, Bolli Martin, Padovan Elisabetta, Zajac Paul, Heberer Michael, Spagnoli Giulio C
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Bolli M, Sauter G, Heberer M, Harder F, Gambazzi F, Mirlacher M, Haas P, Dalquen P, Guller U, Adamina M, Kocher T, Spagnoli G. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236:785-93; discussion 793.
Dec 1, 2002Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Dec 1, 2002Ann Surg 2002; 236:785-93; discussion 793
Bolli Martin, Sauter Guido, Heberer Michael, Harder Felix, Gambazzi Franco, Mirlacher Martina, Haas Philippe, Dalquen Peter, Guller Ulrich, Adamina Michel, Kocher Thomas, Spagnoli Giulio C
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Oertli D, Heberer M, Harder F, Schumacher R, Adamina M, Padovan E, Kocher T, Noppen C, Zajac P, Marti W, Spagnoli G. Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo. Hum Gene Ther 2002; 13:569-75.
Mar 1, 2002Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Mar 1, 2002Hum Gene Ther 2002; 13:569-75
Oertli Daniel, Heberer Michael, Harder Felix, Schumacher Reto, Adamina Michel, Padovan Elisabetta, Kocher Thomas, Noppen Christoph, Zajac Paul, Marti Walter R, Spagnoli Giulio C
Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Spagnoli G, Zajac P, Marti W, Oertli D, Padovan E, Noppen C, Kocher T, Adamina M, Heberer M. Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy. Recent Results Cancer Res 2002; 160:195-201.
Jan 1, 2002Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Jan 1, 2002Recent Results Cancer Res 2002; 160:195-201
Spagnoli Giulio C, Zajac Paul, Marti Walter R, Oertli Daniel, Padovan Elisabetta, Noppen Christoph, Kocher Thomas, Adamina Michel, Heberer Michael